Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: To compare a deep learning (DL)-accelerated non-enhanced abbreviated MRI (AMRI) protocol with standard AMRI (AMRI) of the liver in terms of image quality and malignant focal lesion detection.
BACKGROUND: The cost of health care for patients with Hodgkin lymphoma (HL) is projected to rise, making it essential to understand expenditure drivers across different demographics, including the older adult population. Although older HL patients constitute a significant number of HL patients, the literature on health care expenditures in older HL patients is lacking. Predictive capabilities of m...
TME is a core player in the development of a cancerous lesion, the immune evasive potential of the lesion, and its response to therapy. Sphingolipid m...
Immunotherapy has revolutionized the diagnosis and treatment model for patients with advanced non-small cell lung cancer (NSCLC). Numerous clinical tr...
BACKGROUND: The management of cardiotoxicity related to cancer therapies has emerged as a significant clinical challenge, prompting the rapid growth o...
Background Limited data are available regarding the accuracy of artificial intelligence (AI) algorithms trained on bilateral mammograms for second bre...
Background Standardized bone tumor reporting is crucial for consistent, risk-aligned patient management. Current systems are based on expert consensus...
Microfluidic devices (MDs) present a novel method for detecting circulating tumor cells (CTCs), enhancing the process through targeted techniques and ...
BACKGROUND: Glucose metabolism plays a critical role in the development and progression of kidney renal clear cell carcinoma (KIRC). This study aimed ...
Early detection of gastric cancer, a leading cause of cancer-related mortality worldwide, remains hampered by the limitations of current diagnostic ...
Prostate cancer diagnosis heavily relies on histopathological evaluation, which is subject to variability. While immunohistochemical staining (IHC) ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer, with most cases diagnosed at stage IV and a five-year overall survival rate b...
Leveraging multi-center data for medical analytics presents challenges due to privacy concerns and data heterogeneity. While distributed approaches ...
The complexity and variability inherent in high-resolution pathological images present significant challenges in computational pathology. While path...
Lung cancer is the primary cause of cancer death globally, with non-small cell lung cancer (NSCLC) emerging as its most prevalent subtype. Among NSC...
Accurate evaluation of regional lung ventilation is essential for the management and treatment of lung cancer patients, supporting assessments of pu...
The rapid advancement of deep learning (DL) has transformed healthcare, particularly in cancer detection and diagnosis. DL surpasses traditional mac...
In modern cancer research, the vast volume of medical data generated is often underutilised due to challenges related to patient privacy. The OncoRe...
Oncologists often rely on a multitude of data, including whole-slide images (WSIs), to guide therapeutic decisions, aiming for the best patient outc...
The integration of heterogeneous multi-omics datasets at a systems level remains a central challenge for developing analytical and computational mod...